Trends
Telemedicine and Trust
Telemedicine may be the future of healthcare. Exactly how that future will manifest varies widely. But predicting the future based...
Read more
COVID-19 & The Future of Online News
The recent lockdowns and ongoing restrictions have brought about an increased interest in health and science news online. But a...
Read more
Improving Healthcare By Minimizing Substitution Costs
Healthcare is set to change in novel, unprecedented ways in the years to come. But how we envision these changes...
Read more
Defining Medically Appropriate
A term often used, but poorly defined - yet subject readily to manipulative, self-serving interpretations. Generally assumed to be behavior...
Read more
Narratives – The Future of Healthcare
In today's healthcare, technology and data reign supreme. But as we move forward, first through and then beyond the COVID-19...
Read more
The Story of Pain
In the quantified world of healthcare, we continue to rely upon numbers and data to diagnose and treat patients. And...
Read more
Healthcare Is Dialectic
Healthcare is defined by strongly held views that quickly develop and come into conflict with opposing views that form just...
Read more
Observer Bias Defines How We Look At Ourselves
Observer bias defines the reality we create and the narratives we tell, which may impact how we see the future.
Read more
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more